Targeting PLD6 in both subcutaneous and orthotopic cancer mouse models attenuated tumorigenesis possibly by suppressing Wnt/β-catenin signaling, thereby sensitizing CRC cells to 5-FU-induced apoptosis. This evidence concerns the gene PLD6 and cancer.